Latest headlines
Bristol Myers Squibb News
The latest Bristol Myers Squibb (BMY) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these BMY headlines next to the live Bristol Myers Squibb Fear and Greed Index.
Latest Bristol Myers Squibb Headlines49
Can Eliquis Cushion Bristol Myers' Legacy Portfolio Erosion?
zacks.com · Aug 21, 2026
Here's Why Bristol Myers Squibb (BMY) is a Strong Momentum Stock
zacks.com · Aug 21, 2026
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?
fool.com · Aug 20, 2026
Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery
businesswire.com · Aug 20, 2026
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
zacks.com · Aug 19, 2026
AstraZeneca Vs. Bristol-Myers Squibb: Who's The Better Bargain For Investors?
seekingalpha.com · Aug 19, 2026
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
fool.com · Aug 18, 2026
Can BMY's First CELMoD Approval Support Its Growth Strategy?
zacks.com · Aug 14, 2026
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Aug 14, 2026
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?
fool.com · Aug 14, 2026
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
fool.com · Aug 13, 2026
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
businesswire.com · Aug 13, 2026
US FDA approves Bristol Myers' blood cancer treatment
reuters.com · Aug 13, 2026
Lawsuit against Bristol Myers over delayed cancer drug is revived
reuters.com · Aug 13, 2026
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
prnewswire.com · Aug 13, 2026
Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?
zacks.com · Aug 12, 2026
Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock
fool.com · Aug 11, 2026
BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?
zacks.com · Aug 10, 2026
Bristol Myers to build $2.3 billion manufacturing site in Houston
reuters.com · Aug 10, 2026
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
businesswire.com · Aug 10, 2026
Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade
zacks.com · Aug 6, 2026
Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
businesswire.com · Aug 5, 2026
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
reuters.com · Aug 5, 2026
BMY or AMGN: Which Is the Better Value Stock Right Now?
zacks.com · Aug 4, 2026
Brokers split on AstraZeneca merger talk as shares recover some ground
proactiveinvestors.co.uk · Aug 4, 2026
Are Investors Undervaluing Bristol Myers Squibb (BMY) Right Now?
zacks.com · Aug 4, 2026
Bristol Myers Squibb Company (BMY) Hit a 52 Week High, Can the Run Continue?
zacks.com · Aug 4, 2026
More Biotech M&A Is on the Way, Whether an AstraZeneca-Bristol Myers Deal Happens or Not
barrons.com · Aug 4, 2026
AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus
benzinga.com · Aug 3, 2026
Bristol-Myers stock: why AstraZeneca merger is unlikely to happen
invezz.com · Aug 3, 2026
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term
zacks.com · Aug 3, 2026
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca
investopedia.com · Aug 3, 2026
5 Things to Know Before the Stock Market Opens on Monday
investopedia.com · Aug 3, 2026
Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb
proactiveinvestors.com · Aug 3, 2026
Breakfast News: Pharma's $400B Blockbuster Brewing
fool.com · Aug 3, 2026
Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb
proactiveinvestors.co.uk · Aug 3, 2026
AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
marketwatch.com · Aug 3, 2026
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca
barrons.com · Aug 3, 2026
Why did AstraZeneca shares fall 6% after Bristol Myers Squibb merger reports?
invezz.com · Aug 3, 2026
AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb
proactiveinvestors.com · Aug 3, 2026
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks
wsj.com · Aug 3, 2026
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
cnbc.com · Aug 3, 2026
AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb
proactiveinvestors.co.uk · Aug 3, 2026
AstraZeneca shares tumble 7% after reported Bristol Myers talks
reuters.com · Aug 3, 2026
AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
nypost.com · Aug 2, 2026
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
cnbc.com · Aug 2, 2026
AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, FT reports
reuters.com · Aug 2, 2026
Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That
fool.com · Aug 1, 2026
BMY Q2 Earnings Call Highlights Growth Portfolio Momentum
zacks.com · Jul 31, 2026
Why Is Bristol Myers Squibb Up or Down Today?
When Bristol Myers Squibb (BMY) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a BMY move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Bristol Myers Squibb is up or down today.
How Bristol Myers Squibb News Affects the Price
News does not move the Bristol Myers Squibb (BMY) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Bristol Myers Squibb Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Bristol Myers Squibb trading volume. That is the chain to watch: headline, sentiment, volume, then the BMY price.
Trade the Bristol Myers Squibb News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Bristol Myers Squibb trading volume spike on a big story, check the Bristol Myers Squibb price history for context, follow the live BMY price, see the Bristol Myers Squibb price prediction, and read the Bristol Myers Squibb Fear and Greed Index for mood.
How do you feel about Bristol Myers Squibb?
1DFrequently asked questions
Why is Bristol Myers Squibb up or down today?
What is the latest Bristol Myers Squibb news?
Where does Bristol Myers Squibb news come from?
How often is Bristol Myers Squibb news updated?
How does Bristol Myers Squibb news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.